<DOC>
	<DOCNO>NCT01670838</DOCNO>
	<brief_summary>This prospective cohort study investigate cardiac function cardiac biomarkers patient acute Aneurysmal Subarachnoid Haemorrhage ( aSAH ) . The aim study document incidence myocardial dysfunction , find predictive factor myocardial dysfunction , describe heart rate variability ass impact cardiac problem morbidity mortality .</brief_summary>
	<brief_title>Cardiopulmonary Complication Aneurysmal Subarachnoid Haemorrhage Patients</brief_title>
	<detailed_description>Laboratory marker daily : Routine laboratory test ( blood gas , haemoglobin , thrombocyte , leukocyte , INR , bilirubin , creatinine , c-reactive protein , CK , CK-MB , Tnt , BNP , sodium , potassium , magnesium ) take 8 a.m. Study laboratory test ( sensitive ischemia marker , remodelling marker MMP-9 CgA surrogate marker increase sympathetic activity ) take four time study period time cardiac ECHOes Holtering . Gene sample take day one . Primary outcome measurement document incidence myocardial dysfunction predictive factor hospital stay three month . Secondary outcome assess impact cardiac problem morbidity mortality first three month .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>Patients nontraumatic subarachnoid haemorrhage Age &gt; 18 year Aneurysmal bleed No consent Age &lt; 18 year Anticipated brain death &lt; 24 hour Otherwise moribund patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>subarachnoid haemorrhage</keyword>
	<keyword>cardiopulmonary complication</keyword>
</DOC>